Tools commonly used in the Lyme Disease-Information & Services industry for day-to-day tasks and operations.

• Tick removal tools
• Lyme disease testing kits
• Insect repellent
• Tick identification guides
• Lyme disease treatment guidelines
• Educational materials (brochures, posters, etc.)
• Online forums and support groups
• Lyme disease tracking apps
• Tick surveillance tools
• Lyme disease research databases

Common products and services typical of NAICS Code 621330-06, illustrating the main business activities and contributions to the market.

• Lyme disease prevention
• Tick-borne illness awareness
• Lyme disease treatment options
• Lyme disease research funding
• Tick bite prevention
• Lyme disease advocacy
• Lyme disease testing
• Lyme disease support groups
• Lyme disease education
• Tick control measures

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• International Lyme and Associated Diseases Society (ILADS) Physician Training Program: This program provides physicians with the knowledge and skills necessary to diagnose and treat Lyme disease and other tick-borne illnesses. The program is offered by the International Lyme and Associated Diseases Society (ILADS).
• Council Of State and Territorial Epidemiologists (CSTE) Lyme Disease Case Definition: The CSTE Lyme Disease Case Definition is used by public health officials to track and report cases of Lyme disease. The definition is updated regularly to reflect new information and research.
• International Lyme and Associated Diseases Society (ILADS) Lyme Disease Treatment Guidelines: These guidelines provide evidence-based recommendations for the diagnosis and treatment of Lyme disease and other tick-borne illnesses. The guidelines are updated regularly to reflect new research and information.
• Centers for Disease Control and Prevention (CDC) Tickborne Diseases Laboratory Testing: The CDC provides guidelines for laboratory testing for tick-borne diseases, including Lyme disease. The guidelines include recommendations for which tests to use and how to interpret the results.
• International Lyme and Associated Diseases Society (ILADS) Lyme Disease Diagnostic Guidelines: These guidelines provide evidence-based recommendations for the diagnosis of Lyme disease and other tick-borne illnesses. The guidelines are updated regularly to reflect new research and information.

A concise historical narrative of NAICS Code 621330-06 covering global milestones and recent developments within the United States.

• The "Lyme Disease-Information & Services" industry has its roots in the late 1970s when a group of children in Lyme, Connecticut, developed an unusual set of symptoms, including fever, headache, and a bull's eye rash. The disease was later identified as Lyme disease, caused by the bacterium Borrelia burgdorferi. In the 1980s, the first diagnostic tests for Lyme disease were developed, and the first treatment guidelines were established. In the 1990s, the first Lyme disease vaccine was developed, but it was later withdrawn from the market due to low demand and concerns about side effects. In recent years, the industry has seen a surge in research and development of new diagnostic tests, treatments, and prevention strategies, as well as increased public awareness and advocacy efforts. In the United States, the "Lyme Disease-Information & Services" industry has been shaped by a number of factors, including the growing incidence of Lyme disease, which has increased from around 10,000 cases in 1995 to over 30,000 cases in 2019, according to the Centers for Disease Control and Prevention (CDC). The industry has also been influenced by controversies surrounding the diagnosis and treatment of Lyme disease, as well as by the emergence of new tick-borne diseases, such as Powassan virus and Borrelia miyamotoi. In recent years, the industry has seen increased collaboration between researchers, clinicians, and patient advocates, as well as the development of new technologies and treatment approaches.

The anticipated future trajectory of the NAICS 621330-06 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The Lyme Disease-Information & Services industry is expected to grow in the coming years due to the increasing prevalence of Lyme disease in the United States. According to the Centers for Disease Control and Prevention (CDC), the number of reported cases of Lyme disease has been steadily increasing over the past decade. This trend is expected to continue, which will drive demand for information and services related to the disease. Additionally, advancements in diagnostic testing and treatment options are expected to further drive growth in the industry. However, the industry may face challenges related to the lack of standardized diagnostic testing and the controversy surrounding the diagnosis and treatment of chronic Lyme disease.

Recent groundbreaking advancements and milestones in the Lyme Disease-Information & Services industry, reflecting notable innovations that have reshaped its landscape.

• Tick-Borne Disease Working Group: In 2019, the Tick-borne Disease Working Group, established by the Department of Health and Human Services, released its first report on the federal response to tick-borne diseases. The report includes recommendations for improving diagnosis, treatment, and prevention of tick-borne diseases, including Lyme disease.
• New Diagnostic Tests: Several new diagnostic tests for Lyme disease have been developed in recent years, including the C6 Lyme ELISA test and the Lyme ImmunoBlot test. These tests are more accurate than previous tests and can detect Lyme disease earlier in the infection.
• Lyme Disease Vaccine: In 2019, the French pharmaceutical company Valneva announced that it had received FDA Fast Track designation for its Lyme disease vaccine candidate. The vaccine is currently in Phase 2 clinical trials.
• Lyme Disease Research Funding: In 2020, the National Institutes of Health (NIH) announced that it would be increasing funding for Lyme disease research by $6 million over the next five years. This funding will support research on the diagnosis, treatment, and prevention of Lyme disease.
• Lyme Disease Awareness Campaigns: Several organizations, including the Lyme Disease Association and the Global Lyme Alliance, have launched awareness campaigns to educate the public about Lyme disease and its symptoms. These campaigns aim to increase early detection and treatment of the disease.